Eeltink E, van der Horst M Z, Zinkstok J R, Aalfs C M, Luykx J J
Department of Psychiatry, UMC Utrecht Brain Center, University Medical Center Utrecht, Utrecht University, Utrecht, the Netherlands; Department of Translational Neuroscience, UMC Utrecht Brain Center, University Medical Center Utrecht, Utrecht University, Utrecht, the Netherlands.
Department of Psychiatry, UMC Utrecht Brain Center, University Medical Center Utrecht, Utrecht University, Utrecht, the Netherlands; Department of Translational Neuroscience, UMC Utrecht Brain Center, University Medical Center Utrecht, Utrecht University, Utrecht, the Netherlands; Second Opinion Outpatient Clinic, GGNet Mental Health, Warnsveld, the Netherlands.
Neurosci Biobehav Rev. 2021 Feb;121:119-127. doi: 10.1016/j.neubiorev.2020.11.021. Epub 2020 Dec 7.
Polygenic risk scores (PRS) may aid in the identification of individuals at-risk for psychiatric disorders, treatment optimization, and increase in prognostic accuracy. PRS may also add significant value to genetic counseling. Thus far, integration of PRSs in genetic counseling sessions remains problematic because of uncertainties in risk prediction and other concerns. Here, we review the current utility of PRSs in the context of clinical psychiatry. By comprehensively appraising the literature in other fields of medicine including breast cancer, Alzheimer's Disease, and cardiovascular disease, we outline several lessons learned that could be applied to future studies and may thus benefit the incorporation of PRS in psychiatric genetic counseling. These include integrating PRS with environmental factors (e.g. lifestyle), setting up large-scale studies, and applying reproducible methods allowing for cross-validation between cohorts. We conclude that psychiatry may benefit from experiences in these fields. PRS may in future have a role in genetic counseling in clinical psychiatric practice, by advancing prevention strategies and treatment decision-making, thus promoting quality of life for (potentially) affected individuals.
多基因风险评分(PRS)可能有助于识别有患精神疾病风险的个体、优化治疗并提高预后准确性。PRS 还可能为遗传咨询增添重要价值。到目前为止,由于风险预测的不确定性和其他问题,将 PRS 整合到遗传咨询过程中仍然存在问题。在此,我们回顾了 PRS 在临床精神病学背景下的当前效用。通过全面评估包括乳腺癌、阿尔茨海默病和心血管疾病在内的其他医学领域的文献,我们总结了一些经验教训,这些经验教训可应用于未来的研究,从而可能有利于将 PRS 纳入精神科遗传咨询。这些经验教训包括将 PRS 与环境因素(如生活方式)相结合、开展大规模研究以及应用可重复的方法以便在不同队列之间进行交叉验证。我们得出结论,精神病学可能会从这些领域的经验中受益。未来,PRS 可能通过推进预防策略和治疗决策,从而提高(潜在)受影响个体的生活质量,在临床精神病学实践的遗传咨询中发挥作用。